Menu
Back to User profile » Dr Zancong Shen
Papers published by Dr Zancong Shen:
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects
Hall J, Gillen M, Liu S, Miner JN, Valdez S, Shen Z, Lee C
Drug Design, Development and Therapy 2018, 12:1799-1807
Published Date: 20 June 2018
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects
Shen Z, Gillen M, Miner JN, Bucci G, Wilson DM, Hall JW
Drug Design, Development and Therapy 2017, 11:2077-2086
Published Date: 7 July 2017
Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers
Gillen M, Valdez S, Zhou D, Kerr B, Lee CA, Shen Z
Drug Design, Development and Therapy 2016, 10:3555-3562
Published Date: 1 November 2016
Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study
Shen Z, Gillen M, Tieu K, Nguyen M, Harmon E, Wilson DM, Kerr B, Lee CA
Drug Design, Development and Therapy 2016, 10:3509-3517
Published Date: 27 October 2016
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males
Shen Z, Rowlings C, Kerr B, Hingorani V, Manhard K, Quart B, Yeh LT, Storgard C
Drug Design, Development and Therapy 2015, 9:3423-3434
Published Date: 2 July 2015